Adbry® Resources | Injection Training & Patient Stories

Step-by-step treatment routine

Watch these videos to learn how to inject Adbry.

Questions about self-injecting Adbry? Call the Adbry® Advocate™ Program at 844-MY-ADBRY (844-692-3279) for additional support from a Case Manager.

Autoinjector Training Video (Adults)

See how to use the autoinjector (adult patients)

Prefilled Syringe Training Video (Adults)

See how to use prefilled syringes (adult patients)

Prefilled Syringe Training Video (Pediatric)

See how to give injections to pediatric patients using prefilled syringes

“I spent countless hours, and not to mention a lot of money, on creams and other things that I hoped might bring some relief. Now, I want others to know that there is hope. DON’T GIVE UP!”

JULIE

A REAL ADBRY PATIENT
Individual results may vary.

Real stories. Real people. Real results with Adbry.

Hear from Beth, Kalvin, and Tayttum, 3 Adbry® Voices™ ambassadors, as they share their experience with
moderate-to-severe and their treatment journey with Adbry. Individual results may vary.

Beth: “I’m comfortable in my own skin.”

Kalvin: “It’s a hole in one for me.”

See more of Kalvin’s story

Tayttum: “I have trust in my skin now.”

Quick access links to resources

Instructions for Use (English)

Instructions for Use (Spanish)

Patient Brochure (English)

Patient Brochure (Spanish)

Training Demonstration Guide (Syringe)

Training Demonstration Guide (Autoinjector)

See how to use the autoinjector (adult patients)

See how to use prefilled syringes (adult patients)

See how to give injections to pediatric patients using prefilled syringes

Beth’s story: “I’m comfortable in my own skin.”

Kalvin’s story: “It’s a hole in one for me.”

Tayttum’s story: “I have trust in my skin now.”

Patient Consent Form

Keep learning about Adbry:

What is Adbry?

Learn how it works

Adbry clinical results

See what’s possible

Savings programs

Find support options

INDICATION

What is ADBRY?

ADBRY® (tralokinumab-ldrm) injection is a prescription medicine used to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
It is not known if ADBRY is safe and effective in children under 12 years of age.

Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.

Please see full Prescribing Information, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

What should I discuss with my healthcare provider before starting ADBRY?

Tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with ADBRY.
are pregnant or plan to become pregnant. It is not known whether ADBRY will harm your unborn baby. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. You or your healthcare provider can get information and enroll you in this registry by calling 1-877-311-8972 or visiting https://mothertobaby.org/ongoing-study/adbry-tralokinumab/.
are breastfeeding or plan to breastfeed. It is not known whether ADBRY passes into your breast milk and if it can harm your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ADBRY?

See the detailed “Instructions for Use” that comes with ADBRY for information on how to prepare and inject ADBRY and how to properly store and throw away (dispose of) used ADBRY prefilled syringes and autoinjectors.
Use ADBRY exactly as prescribed by your healthcare provider.
Your healthcare provider will tell you how much ADBRY to inject and when to inject it.
ADBRY comes as a single-dose prefilled syringe with needle guard or as an autoinjector.
ADBRY is given as an injection under the skin (subcutaneous injection).
If your healthcare provider decides that you or a caregiver can give the injections of ADBRY, you or your caregiver should receive training on the right way to prepare and inject ADBRY. Do not try to inject ADBRY until you have been shown the right way by your healthcare provider. In children 12 years of age and older, it is recommended that ADBRY be given by or under supervision of an adult.
If you miss a dose, inject the missed dose as soon as possible, then continue with your next dose at your regular scheduled time.
If you inject too much ADBRY than prescribed, call your healthcare provider or call Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Your healthcare provider may prescribe other medicines to use with ADBRY. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of ADBRY?

ADBRY can cause serious side effects, including:

Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Stop using ADBRY and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- breathing problems
- itching
- skin rash
- swelling of the face, mouth, and tongue
- fainting, dizziness, feeling lightheaded (low blood pressure)
- hives

Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision.

The most common side effects of ADBRY include:

Upper respiratory tract infections
Eye and eyelid inflammation, including redness, swelling, and itching
Injection site reactions
High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read more Collapse